Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Jul;50(7):566–568. doi: 10.1136/jcp.50.7.566

Sputum cytology: a limited role.

A Gledhill 1, C Bates 1, D Henderson 1, P DaCosta 1, G Thomas 1
PMCID: PMC500053  PMID: 9306936

Abstract

AIMS: To determine the cost and sensitivity of sputum cytology in routine use and to determine when sputum cytology is most appropriate. METHODS: A retrospective study, based on all sputum cytology requests received in five histopathology/cytopathology laboratories in Yorkshire from 1 January to 31 December 1993. Cytology findings were correlated with histological diagnosis or clinical outcome, and related to the speciality of the referring clinician. RESULTS: Laboratory practice and performance was similar in all five centres. The average laboratory cost of sputum cytology was 26.93. The mean absolute sensitivity was 36% and the specificity was 99.6%. The majority of specimens was submitted by general physicians or geriatricians. The largest proportion of positive specimens were submitted by chest physicians. CONCLUSIONS: Often sputum cytology is used inappropriately as a screening investigation on, or soon after, admission. In addition, it is used inappropriately before bronchoscopy. Sputum cytology should be limited to individuals in whom a histological diagnosis is desired, but in whom bronchoscopy is inappropriate or unsuccessful.

Full text

PDF
566

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benbassat J., Regev A., Slater P. E. Predictive value of sputum cytology. Thorax. 1987 Mar;42(3):165–172. doi: 10.1136/thx.42.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Erozan Y. S., Frost J. K. Cytopathologic diagnosis of cancer in pulmonary material: a critical histopathologic correlation. Acta Cytol. 1970 Nov-Dec;14(9):560–565. [PubMed] [Google Scholar]
  3. Fraire A. E., McLarty J. W., Greenberg S. D. Changing utilization of cytopathology versus histopathology in the diagnosis of lung cancer. Diagn Cytopathol. 1991;7(4):359–362. doi: 10.1002/dc.2840070407. [DOI] [PubMed] [Google Scholar]
  4. Johnston W. W., Bossen E. H. Ten years of respiratory cytopathology at Duke University Medical Center. I. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol. 1981 Mar-Apr;25(2):103–107. [PubMed] [Google Scholar]
  5. Piaton E., Grillet-Ravigneaux M. H., Saugier B., Pellet H. Prospective study of combined use of bronchial aspirates and biopsy specimens in diagnosis and typing of centrally located lung tumours. BMJ. 1995 Mar 11;310(6980):624–627. doi: 10.1136/bmj.310.6980.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Tanaka T., Yamamoto M., Tamura T., Moritani Y., Miyai M., Hiraki S., Ohnoshi T., Kimura I. Cytologic and histologic correlation in primary lung cancer. A study of 154 cases with resectable tumors. Acta Cytol. 1985 Jan-Feb;29(1):49–56. [PubMed] [Google Scholar]
  7. Truong L. D., Underwood R. D., Greenberg S. D., McLarty J. W. Diagnosis and typing of lung carcinomas by cytopathologic methods. A review of 108 cases. Acta Cytol. 1985 May-Jun;29(3):379–384. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES